![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 215/22 | |
C07C 305/24 | |||
C07C 233/60 | |||
A61K 31/47 | |||
A61P 35/00 | |||
C07D 215/60 | |||
G01N 33/487 |
(11) | Patento numeris | 2970126 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 14721149.4 |
Europos patento paraiškos padavimo data | 2014-03-17 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2014/030524 |
Data | 2014-03-17 |
(87) | Numeris | WO 2014/145715 |
Data | 2014-09-18 |
(30) | Numeris | Data | Šalis |
201361792413 P | 2013-03-15 | US |
(72) |
AFTAB, Dana, T., US
NAGANATHAN, Sriram, US
XU, Wei, US
LACY, Steven, US
NGUYEN, Linh, US
|
(73) |
Exelixis, Inc.,
1851 Harbor Bay Parkway, Alameda, CA 94502,
US
|
(54) | METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N`-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE |
METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N`-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE |